Cleared Traditional

K221462 - DePuy Reclaim Monobloc Revision Femoral Stem

K221462 is an FDA 510(k) clearance for DePuy Reclaim Monobloc Revision Femoral..., manufactured by Depuy Ireland UC. The device is a Class 2 Orthopedic device with product code LZO cleared through the Traditional 510(k) pathway after a 155-day FDA review.

K221462 · Depuy Ireland UC · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
155d
Days
Class 2
Risk

K221462 is an FDA 510(k) clearance for the DePuy Reclaim Monobloc Revision Femoral Stem. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Depuy Ireland UC (Loughbeg, IE). The FDA issued a Cleared decision on October 21, 2022 after a review of 155 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Depuy Ireland UC devices

FDA 510(k) Submission Details - K221462

510(k) Number K221462 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 19, 2022
Decision Date October 21, 2022
Days to Decision 155 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 122d · This submission: 155d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZO Device Classification - Class 2, Special Controls

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 507
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K221462.
BENCOX Delta Option Heads
K223828 · Corentec Co., Ltd. · Mar 2023
ARTICUL/EZE Ceramic Heads
K222296 · Depuy Ireland UC · Jan 2023
U-Motion II Acetabular System-Extension line
K221149 · United Orthopedic Corporation · Jan 2023
Platform® Acetabular System
K220483 · Total Joint Orthopedics, Inc. · Sep 2022
SP-CL Hip Stem and LCU Hip System
K213770 · Waldemar Link GmbH & Co. KG · Sep 2022
implaFit® hip stems
K210678 · Implantcast GmbH · Aug 2022